186 related articles for article (PubMed ID: 22415444)
1. Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibition.
Gusain A; Hatcher JF; Adibhatla RM; Wesley UV; Dempsey RJ
Mol Neurobiol; 2012 Jun; 45(3):455-64. PubMed ID: 22415444
[TBL] [Abstract][Full Text] [Related]
2. Protection by D609 through cell-cycle regulation after stroke.
Adibhatla RM; Hatcher JF
Mol Neurobiol; 2010 Jun; 41(2-3):206-17. PubMed ID: 20148315
[TBL] [Abstract][Full Text] [Related]
3. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?
Luberto C; Hannun YA
J Biol Chem; 1998 Jun; 273(23):14550-9. PubMed ID: 9603970
[TBL] [Abstract][Full Text] [Related]
4. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
Adibhatla RM; Hatcher JF; Gusain A
Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
[TBL] [Abstract][Full Text] [Related]
5. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.
Larsen EC; Hatcher JF; Adibhatla RM
Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680
[TBL] [Abstract][Full Text] [Related]
6. Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications.
Bhat AH; Dar KB; Khan A; Alshahrani S; Alshehri SM; Ghoneim MM; Alam P; Shakeel F
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328726
[TBL] [Abstract][Full Text] [Related]
7. Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells.
Meng A; Luberto C; Meier P; Bai A; Yang X; Hannun YA; Zhou D
Exp Cell Res; 2004 Jan; 292(2):385-92. PubMed ID: 14697345
[TBL] [Abstract][Full Text] [Related]
8. The tricyclodecan-9-yl-xanthogenate D609 triggers ceramide increase and enhances FasL-induced caspase-dependent and -independent cell death in T lymphocytes.
Milhas D; Andrieu-Abadie N; Levade T; Benoist H; Ségui B
Int J Mol Sci; 2012; 13(7):8834-8852. PubMed ID: 22942738
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner.
Ito J; Nagayasu Y; Ueno S; Yokoyama S
J Biol Chem; 2002 Nov; 277(47):44709-14. PubMed ID: 12228236
[TBL] [Abstract][Full Text] [Related]
10. The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609.
Perry RJ; Ridgway ND
J Lipid Res; 2004 Jan; 45(1):164-73. PubMed ID: 13130125
[TBL] [Abstract][Full Text] [Related]
11. Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609).
Tschaikowsky K; Meisner M; Schönhuber F; Rügheimer E
Br J Pharmacol; 1994 Nov; 113(3):664-8. PubMed ID: 7532078
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
[TBL] [Abstract][Full Text] [Related]
13. Regulation of neural progenitor cell proliferation by D609: potential role for ERK.
Kalluri HS; Gusain A; Dempsey RJ
Mol Neurobiol; 2013 Apr; 47(2):782-9. PubMed ID: 23275176
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
15. D609 inhibits the proliferation of neural progenitor cells.
Kalluri HS; Dempsey RJ
Neuroreport; 2010 Jul; 21(10):700-3. PubMed ID: 20568314
[TBL] [Abstract][Full Text] [Related]
16. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages.
Monick MM; Carter AB; Gudmundsson G; Mallampalli R; Powers LS; Hunninghake GW
J Immunol; 1999 Mar; 162(5):3005-12. PubMed ID: 10072552
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
Singh AT; Radeff JM; Kunnel JG; Stern PH
Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
[TBL] [Abstract][Full Text] [Related]
18. Ceramide does not inhibit protein kinase C beta-dependent phospholipase D activity stimulated by anti-Fas monoclonal antibody in A20 cells.
Han J; Shin I
Cell Signal; 2000 Dec; 12(11-12):731-6. PubMed ID: 11152958
[TBL] [Abstract][Full Text] [Related]
19. Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene.
Burns TA; Subathra M; Signorelli P; Choi Y; Yang X; Wang Y; Villani M; Bhalla K; Zhou D; Luberto C
J Lipid Res; 2013 Mar; 54(3):794-805. PubMed ID: 23160178
[TBL] [Abstract][Full Text] [Related]
20. Chronic D609 treatment interferes with cell cycle and targets the expression of Olig2 in Glioma Stem like Cells.
Kalluri HSG; Kuo JS; Dempsey RJ
Eur J Pharmacol; 2017 Nov; 814():81-86. PubMed ID: 28802717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
